Classic, "buy on the rumor, sell on the news". We knew this was coming.
Still, it's a nice bump / Price $1.49 / Day's Change +0.17 (+12.88%). Don't tear up
Volume(Heavy Day) Today's volume of 78,508 shares is on pace to be much greater than ODYY's 10-day average volume of 84,277 shares.
March 03, 2021 2:26pm ET
I expect we'll retrace on no news over the coming weeks/months, though these people seem dead set on not allowing there to be a vacuum to suck up the enthusiasm and deaden the PPS. They seem focused on pumping it up.
Look for more opportunities to add. Don't be surprised if they do a diluting equity raise to pay for the phase 1 trial.
Given that they might do just that, I will wait to add after that event.
Whenever they start announcing things related to the trial, watch for a bump then.
Still, it's a nice bump / Price $1.49 / Day's Change +0.17 (+12.88%). Don't tear up
Volume(Heavy Day) Today's volume of 78,508 shares is on pace to be much greater than ODYY's 10-day average volume of 84,277 shares.
March 03, 2021 2:26pm ET
I expect we'll retrace on no news over the coming weeks/months, though these people seem dead set on not allowing there to be a vacuum to suck up the enthusiasm and deaden the PPS. They seem focused on pumping it up.
Look for more opportunities to add. Don't be surprised if they do a diluting equity raise to pay for the phase 1 trial.
Given that they might do just that, I will wait to add after that event.
Whenever they start announcing things related to the trial, watch for a bump then.
joepcf
Wednesday, 03/03/21 02:03:13 PM
Re: FUNMAN post# 81
Post # 84 of 84
Surprised this is not much higher on this news. Added to my position today
Recent ODYY News
- Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth • PR Newswire (US) • 04/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 10:10:25 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/31/2025 05:15:31 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 02:00:12 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/19/2025 10:10:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/11/2025 10:10:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 02:00:27 PM
- Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million • GlobeNewswire Inc. • 11/19/2025 01:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/29/2025 09:11:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 09:10:25 PM
- Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace • GlobeNewswire Inc. • 10/16/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:10:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2025 09:11:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2025 09:10:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 09:10:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/20/2025 02:56:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2025 09:10:26 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/15/2025 08:18:01 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/15/2025 06:25:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 09:10:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2025 09:02:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2025 09:01:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2025 09:10:10 PM
